This comprehensive course is designed to navigate the complex world of novel pharmaceuticals that gained FDA approval in the previous year. The course offers a deep dive into the 37 new pharmaceutical agents, highlighting the fact that 54% of these were first-in-class. Healthcare professionals will be educated on how these new agents align with current management guidelines, their mechanism of action, dosing, side effects, clinical efficacy, and costs. Special emphasis will be placed on agents related to Ambulatory Care practice models as they represent the majority of 2022’s approved drugs.

The course content is methodically arranged according to organ systems, making it easier for learners to integrate this knowledge into existing management guidelines for conditions such as cardiovascular disease and diabetes. Detailed information on each agent’s class designation, mechanism of action, dosing, clinical efficacy, side effects, and cost will be provided. The course concludes with a set of practical recommendations and a discussion on maintaining up-to-date practice standards in the ever-evolving healthcare landscape.

At the conclusion of this continuing education activity, the participant will be able to:

1. Identify the new pharmaceutical agents available for clinical practice.
2. Outline the use of new pharmaceutical agents in clinical practice.
3. Explain the benefits, risks, and alternatives of new pharmaceutical agents.

AchieveCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. AchieveCE is also accredited by the Florida Board of Pharmacy (provider no. 50-20641).

AchieveCE is designated as an Approved PACE Program Provider by the Academy of General Dentistry. The formal continuing education programs of this program provider are accepted by the AGD for Fellowship/Mastership and membership maintenance credit. Approval does not imply acceptance by a state or provincial board of dentistry or AGD endorsement. The current term of approval extends from September 1, 2022 to August 31, 2025. Provider ID# 386503.

AchieveCE is an approved provider of nursing continuing professional development by the Georgia Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

AchieveCE is also an approved provider by various state boards. Find the complete list here.

Dr. Tim Brown is the Director of Interprofessional Education for the University of Georgia’s College of Pharmacy and Professor in Pharmacology and Toxicology for Augusta University Medical College of Georgia and UGA Partnership. He received his doctorate from Campbell University School of Pharmacy and completed residency training at the Medical College of Virginia. In 2018, Brown was named the Ohio Health-System Pharmacist of the Year and received the Cleveland Clinic Akron General Graduate Medical Education Leader of the year award.

This activity was developed by AchieveCE free of any commercial support.

Tim Brown, PharmD, BCACP, FASHP, faculty for this educational event, has no relevant financial relationship(s) with ineligible companies to disclose. Pete Kreckel, RPh, planner for this activity, also has no relevant financial relationship(s) with ineligible companies to disclose.

  Level 2. Basic Application of Skills and Concepts